80057731 - 11th Biennial Johns Hopkins Breast Cancer Conference: A Multidisciplinary Perspective

Friday, April 29, 2022, 8:15 AM - 5:00 PM, Internet Live Conference


Since our last conference, management and overall care needs of patients with breast cancer has become increasingly complex, especially in light of the ongoing COVID-19 pandemic. Key recent changes include availability of multiple new agents, advances in the use of immunotherapy and targeted therapies, and further integration of genomic platforms into therapeutic decision making. Optimizing breast cancer outcomes and minimizing toxicities of therapy requires individualized decision making and, often, complex multi-disciplinary care. This conference will provide updates in the management of metastatic breast cancer with a special session focused on multi-disciplinary care of central nervous system metastases. In addition, the conference will explore the impact of the COVID-19 pandemic on breast cancer diagnosis and care, offer updates on supportive care for patients with breast cancer. Participants will also learn to optimize therapy for early stage breast cancer by incorporating immunotherapy for triple negative disease and by utilizing genomic assays and other tools to guide therapy for hormone-receptor positive disease in both pre- and post-menopausal patients.

WHO SHOULD ATTEND
This activity is intended for radiologists, pathologists, surgeons, medical and radiation oncologists, internists, gynecologists, family practice physicians, nurses, nurse practitioners, physician assistants and other professionals involved in prevention, screening, diagnosis and management of breast cancer.

FEES
Physicians ........................................................................................................$175
Residents*/Fellows*/Nurses/NPs/PAs/Allied Health Professionals ........ $125
*with verification of status

LATE FEE AND REFUND POLICY
A $25 late fee applies to registrations received after 5:00 p.m. ET on April 23, 2022. A handling fee of $25 will be deducted for cancellation. Refund requests must be received by fax or mail by April 23, 2022. No refunds will be made thereafter. Transfer of registration to another Johns Hopkins activity in lieu of cancellation is not possible.

1. Describe new data and discuss ongoing controversies in the management of early stage and advanced breast cancer.
2. Apply evolving data to individualizing breast cancer management.
3. Identify ways in which the COVID-19 pandemic has affected breast diagnosis and care.

ACCREDITATION STATEMENT
The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT
The Johns Hopkins University School of Medicine designates this live activity for a maximum of 6.25 AMA PRA Category 1 Credits™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

OTHER CREDITS
American Academy of Nurse Practitioners National Certification Program accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.

American Nurses Credentialing Center (ANCC) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.

PAs may claim a maximum of 6.25 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.

The Johns Hopkins University has approved this activity for 6.25 contact hours for non-physicians.

Mitigation of Relevant Financial Relationships

Johns Hopkins University adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Friday, April 29, 2022